![Amy Moore: BIG DEAL for those living with small cell lung cancer](https://oncodaily.com/pub/uploads/2024/05/GNz1tIlX0AA0Hjk.jpeg)
Photo taken from LUNGevity Foundation/X
May 20, 2024, 13:49
Amy Moore: BIG DEAL for those living with small cell lung cancer
Amy Moore, VP of Global Engagement and Patient Partnerships, LUNGevity Foundation, shared a post by LUNGevity Foundation on X, adding the following:
“This is a BIG DEAL for those living with small cell lung cancer. Using “targeted immunotherapy” that tethers the cancer cell and a T cell (a type of immune cell), you can cause the cancer cell to burst. This is a new era for how researchers are approaching this and other cancers.”
Quoting LUNGevity Foundation’s post:
“FDA Accelerated Approval Alert!
The US Food and Drug Administration (FDA) announced the accelerated approval of tarlatamab-dlle (Imdelltra®) to treat patients with extensive-stage small cell lung cancer (SCLC). Learn more.”
Source: Amy Moore/X and LUNGevity Foundation/X
.
Accelerated Approval
Amy Moore
cancer
cancer cell burst
Cancer research
extensive-stage SCLC
FDA approval
Imdelltra
immunotherapy advances
innovative therapy
LUNGevity Foundation
new cancer treatment
OncoDaily
Oncology
SCLC treatment
small cell lung cancer
T cells
Targeted Immunotherapy
tarlatamab-dlle